To elucidate the biological impact and mechanism of KAT6B::ADK in HR+/HER2‒ breast cancer progression, we initially tested the presence of KAT6B::ADK fusion genes in HR+/HER2‒ cell lines. This evidence concerns the gene KAT6B and breast carcinoma.